These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26358613)

  • 1. Influence of mutation and recombination on HIV-1 in vitro fitness recovery.
    Arenas M; Lorenzo-Redondo R; Lopez-Galindez C
    Mol Phylogenet Evol; 2016 Jan; 94(Pt A):264-70. PubMed ID: 26358613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence.
    Bordería AV; Lorenzo-Redondo R; Pernas M; Casado C; Alvaro T; Domingo E; Lopez-Galindez C
    PLoS One; 2010 Apr; 5(4):e10319. PubMed ID: 20436678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
    Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
    J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of in vitro fitness recovery of HIV-1.
    Lorenzo-Redondo R; Bordería AV; Lopez-Galindez C
    J Virol; 2011 Feb; 85(4):1861-70. PubMed ID: 21106747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation and recombination in pathogen evolution: Relevance, methods and controversies.
    Arenas M; Araujo NM; Branco C; Castelhano N; Castro-Nallar E; Pérez-Losada M
    Infect Genet Evol; 2018 Sep; 63():295-306. PubMed ID: 28951202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
    Kühnert D; Kouyos R; Shirreff G; Pečerska J; Scherrer AU; Böni J; Yerly S; Klimkait T; Aubert V; Günthard HF; Stadler T; Bonhoeffer S;
    PLoS Pathog; 2018 Feb; 14(2):e1006895. PubMed ID: 29462208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombination accelerates adaptation on a large-scale empirical fitness landscape in HIV-1.
    Moradigaravand D; Kouyos R; Hinkley T; Haddad M; Petropoulos CJ; Engelstädter J; Bonhoeffer S
    PLoS Genet; 2014 Jun; 10(6):e1004439. PubMed ID: 24967626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of recombination on acquisition and reversion of immune escape and compensatory mutations in HIV-1.
    Nagaraja P; Alexander HK; Bonhoeffer S; Dixit NM
    Epidemics; 2016 Mar; 14():11-25. PubMed ID: 26972510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constraints from protein structure and intra-molecular coevolution influence the fitness of HIV-1 recombinants.
    Woo J; Robertson DL; Lovell SC
    Virology; 2014 Apr; 454-455():34-9. PubMed ID: 24725929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV evolutionary dynamics within and among hosts.
    Lemey P; Rambaut A; Pybus OG
    AIDS Rev; 2006; 8(3):125-40. PubMed ID: 17078483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population.
    Immonen TT; Conway JM; Romero-Severson EO; Perelson AS; Leitner T
    PLoS Comput Biol; 2015 Dec; 11(12):e1004625. PubMed ID: 26693708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Looking for the optimal rate of recombination for evolutionary dynamics.
    Saakian DB
    Phys Rev E; 2018 Jan; 97(1-1):012409. PubMed ID: 29448332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombination increases human immunodeficiency virus fitness, but not necessarily diversity.
    Vijay NNV; Vasantika ; Ajmani R; Perelson AS; Dixit NM
    J Gen Virol; 2008 Jun; 89(Pt 6):1467-1477. PubMed ID: 18474563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection.
    Batorsky R; Kearney MF; Palmer SE; Maldarelli F; Rouzine IM; Coffin JM
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5661-6. PubMed ID: 21436045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombination rate and selection strength in HIV intra-patient evolution.
    Neher RA; Leitner T
    PLoS Comput Biol; 2010 Jan; 6(1):e1000660. PubMed ID: 20126527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission.
    Sanborn KB; Somasundaran M; Luzuriaga K; Leitner T
    Retrovirology; 2015 Nov; 12():96. PubMed ID: 26573574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution during primary HIV infection does not require adaptive immune selection.
    Swan DA; Rolland M; Herbeck JT; Schiffer JT; Reeves DB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35145025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bacterial recombination on adaptation on fitness landscapes with limited peak accessibility.
    Moradigaravand D; Engelstädter J
    PLoS Comput Biol; 2012; 8(10):e1002735. PubMed ID: 23133344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
    Menzo S; Castagna A; Monachetti A; Hasson H; Danise A; Carini E; Bagnarelli P; Lazzarin A; Clementi M
    New Microbiol; 2004 Apr; 27(2 Suppl 1):51-61. PubMed ID: 15646065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of K65K and K66K in HIV-1 subtype B reverse transcriptase.
    Telwatte S; Brumme CJ; Hearps AC; Latham CF; Hayward JA; Sonza S; Sluis-Cremer N; Harrigan PR; Tachedjian G
    AIDS; 2016 Nov; 30(18):2787-2793. PubMed ID: 27677159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.